ÂÜÀòÂÒÂ×

Gwangseong Kim, PhD is a Principal Scientist with expertise in R&D, analytical methods, and formulation development. Kim has experience in leading projects related to nutraceuticals, oncology drugs, infectious diseases, and COVID-related treatments. With a background in biomedical engineering and chemical engineering, Kim has worked in various roles in companies such as VitaKey Inc., L.E.A.F. Pharmaceuticals, and Kytaro Inc. Kim's specialties include LC-MS/MS bioanalytical method development, drug formulation, and team management. Additionally, Kim has served as a CTO and has experience in launching start-up companies.